Evoke Pharma, Inc. (NasdaqCM:EVOK) will look for acquisitions. Evoke Pharma announced that it intends to offer and sell shares of its common stock in a "firm commitment" underwritten public offering. Evoke intends to use the net proceeds from the offering for working capital and general corporate purposes, including funding commercialization activities, research and development activities, clinical trial expenditures, and possible acquisition of new technologies or products.